Providence, RI: Cannabis use is not associated with increased mortality risk in HIV-infected men, according to data published online ahead of print in the journal AIDS and Behavior.
A team of investigators from the Veterans Administration, Brown University, Yale University, the University of Pittsburgh, and the National Institutes of Health assessed drug use and mortality in a cohort of 3,099 HIV-positive men over a nine-year period.
Both the use of alcohol and stimulants were associated with negative effects on five-year mortality risk. By contrast, cannabis use was not independently associated with mortality risk.
For more information, contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org. Full text of the study, “Association of cannabis, stimulant, and alcohol use with mortality prognosis among HIV-infected men,” appears in AIDS and Behavior.